BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Merck
Federal Trade Commission
Covington
Harvard Business School
Teva
US Department of Justice
Cantor Fitzgerald
McKinsey
Mallinckrodt

Generated: January 16, 2018

DrugPatentWatch Database Preview

Anacor Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ANACOR PHARMS INC, and when can generic versions of ANACOR PHARMS INC drugs launch?

ANACOR PHARMS INC has two approved drugs.

There are nine US patents protecting ANACOR PHARMS INC drugs.

There are ninety-nine patent family members on ANACOR PHARMS INC drugs in twenty-two countries.

Summary for Anacor Pharms Inc
International Patents:99
US Patents:9
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Anacor Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Anacor Pharms Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,889,656 Boron-containing small molecules ➤ Subscribe
7,767,657 Boron-containing small molecules ➤ Subscribe
9,029,353 Boron-containing small molecules as anti-inflammatory agents ➤ Subscribe
8,115,026 Boron-containing small molecules ➤ Subscribe
9,353,133 Boron-containing small molecules ➤ Subscribe
8,722,917 Boron-containing small molecules ➤ Subscribe
8,440,642 Boron-containing small molecules ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Anacor Pharms Inc Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Accenture
Express Scripts
US Department of Justice
McKesson
Farmers Insurance
Boehringer Ingelheim
Federal Trade Commission
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot